Conradi Lenard

Lenard Conradi

Cardiac surgeon
Uniklinik Köln - Köln, Germany

Latest contributions

Optimising self-expandable TAVI clinical outcomes without compromise

22 May 2025 – From EuroPCR 2025

Optimising patient outcomes in self-expandable TAVI starts with a clear plan for today, and tomorrow. This EuroPCR 2025 session explores how to make each step count, from access to implantation and closure, using a real-life case of a 77-year-old woman with severe symptomatic aortic stenosis and...

Optimising self-expandable TAVI clinical outcomes without compromise

TAVI for bioprosthetic valve failure - LIVE Case

22 May 2025 – From EuroPCR 2025

A 68-year-old male patient with a history of Sapien 3 26 mm TAVI (2021), complicated by the need for two valves (one displaced in the descending aorta) and permanent pacemaker implantation, as well as endocarditis (2022), presented with symptomatic bioprosthesis failure and reduced LV function (20...

TAVI for bioprosthetic valve failure - LIVE Case

How to improve TAVI durability - LIVE case

26 Nov 2024 – From PCR London Valves 2024

Explore two fascinating cases tackling severe aortic valve challenges with innovative approaches:

  • LIVE Case: An 84-year-old woman with a history of breast cancer and TAVI (Evolut Pro 29) in 2016, presenting with symptomatic severe TAVI stenosis. CT revealed a true ID of 19 mm. The team implanted...
TAVI durability and treatment options

Zero-contrast TAVI while using a novel full-body embolic protection filter

26 Nov 2024 – From PCR London Valves 2024

Discover the latest advancements in zero-contrast TAVI through this case-based session. Learn when to consider a zero-contrast protocol, gain practical insights on performing the procedure, and explore a novel full-body embolic protection filter designed to enhance safety during transcatheter interventions.

Zero-contrast TAVI while using a novel full-body embolic protection filter

New iterations of self expendable valves - LIVE case

25 Nov 2024 – From PCR London Valves 2024

Watch a LIVE case followed by a recorded case on enhanced TAVI:

  • An 80-year-old female with severe symptomatic aortic stenosis, a complete right bundle branch block (RBB), and preserved LV function. The operators implanted a 25 mm ACURATE Prime valve following predilation with a 22 mm balloon....
New iterations of self expendable valves

PCR Tricuspid Focus Group - Referral Meeting in Cologne

13 Jun 2024

Join your peers for this meeting on 5 November 2025 in Cologne, Germany!

Edge-to-edge repair for primary mitral regurgitation: the good, the bad and the ugly

16 May 2024 – From EuroPCR 2024

Discover how to select suitable patients for TEER of primary mitral regurgitation, tackle anatomical challenges, understand the technique's limits, and gain insights into managing complexities and identifying cases where TEER may not be ideal.

Edge-to-edge repair for primary mitral regurgitation: the good, the bad and the ugly

When mitral valve intervention goes wrong

16 May 2024 – From EuroPCR 2024

This session examines various complications that can arise during mitral valve interventions, such as iatrogenic aortic root perforation, unexpected leakage, and other challenging scenarios. The presenters share their experiences in managing these complications and the strategies they employed to address them. The session emphasizes the importance...

When mitral valve intervention goes wrong

Asymptomatic severe aortic stenosis: Will these trials change my practice?

16 May 2024 – From EuroPCR 2024

This session, in collaboration with Partners in Learning, explores the emerging evidence on the use of transcatheter aortic valve implantation (TAVI) in patients with asymptomatic severe aortic stenosis. It covers data from registries and randomized controlled trials, the current guideline recommendations, and the potential impact of...

Asymptomatic severe aortic stenosis

Has the 2023 ESC-EACTS guideline review on left main changed my practice?

15 May 2024 – From EuroPCR 2024

Watch this session if you wish to learn why the 2019 guidelines were revised, how to apply the updated recommendations in clinical settings through case examples, and the criteria for selecting patients with left main stenosis for PCI versus CABG.
The session includes detailed presentations on...

Has the 2023 ESC-EACTS guideline review on left main changed my practice

Current strategies for surgical and transcatheter tricuspid valve repair and replacement

05 Dec 2023 – From PCR London Valves 2023

Watch this roundtable discussion between Julien Dreyfus, Lenard Conradi and Philipp Lurz to learn more about the latest developments in tricuspid regurgitation treatment. They begin by stressing the importance of disease status, which must be assessed quickly and accurately, and of the balance to be reached...

Current strategies for surgical and transcatheter tricuspid valve repair and replacement

Who are eligible patients for transcatheter mitral valve replacement?

05 Dec 2023 – From PCR London Valves 2023

While surgical mitral valve replacement or repair and transcatheter edge-to-edge repair (TEER) are two well established techniques, Alison Duncan and Lenard Conradi explore the place that transcatheter mitral valve replacement (TMVR) now holds.

They describe how and why patients who, for clinical reasons, are not suitable candidates...

Who are eligible patients for transcatheter mitral valve replacement? - PCR London Valves 2023

Mitral valve intervention in complex scenarios - Transcatheter mitral valve replacement - who are the eligible patients, and what are the available options?

21 Nov 2023 – From PCR London Valves 2023

This PCR London Valves 2023 session about mitral valve interventions seeks to address three key questions: identifying the ideal patient for Transcatheter Mitral Valve Implantation (TMVI), exploring treatment alternatives for ineligible patients, and discussing the prediction and management of left ventricular outflow tract obstruction. Watch video...

Mitral valve intervention in complex scenarios - Transcatheter mitral valve replacement - who are the eligible patients, and what are the available options?

Mitral valve interventions in challenging clinical situations

21 Nov 2023 – From PCR London Valves 2023

Discover innovative approaches to mitral valve interventions in challenging clinical situations: navigate the challenges of critical stenosis in a bioprosthetic mitral valve, learn more about the use of iVAC-2L in transcatheter edge-to-edge repair for a mitral valve lacking leaflet coaptation, explore mitral transcutaneous edge-to-edge repair guided by transthoracic...

Mitral valve interventions in challenging clinical situations

Transcatheter mitral valve replacement - The wait will be worth it

20 Nov 2023 – From PCR London Valves 2023

Reflect on the past decade of Transcatheter Mitral Valve Replacement (TMVR) to uncover technical and clinical challenges and the lessons they've taught. Explore innovative technologies addressing persistent issues, offering solutions and anticipated timelines. Additionally, delve into the present and future trial designs, exploring the evidence required for...

Transcatheter mitral valve replacement - The wait will be worth it

Transcatheter mitral valve replacement

20 Nov 2023 – From PCR London Valves 2023

Consult this session for key insights into diverse TMVR challenges: discover unique scenarios such as para-holes post-Tendyne implant, TMVR in a patient with severe mitral annular calcification, a complex case involving mitral para-ring leak and stenosis with a two-step treatment and an atypical LAMPOON indication, and more!

Transcatheter mitral valve replacement

Multivessel disease, which patients for PCI, CABG or medical treatment?

17 May 2023 – From EuroPCR 2023

Because multivessel disease raises many challenges, cardiac surgeon Lenard Conradi and interventional cardiologist Davide Capodanno discuss the biggest ones.

Is invasive coronary angiography really necessary? If revascularisation is required, which patient should be given a PCI rather than a CABG, and vice versa? What is state-of-the-art in surgery in...

Multivessel disease, which patients for PCI, CABG or medical treatment?

Multivessel disease - Which patients for PCI, CABG or medical treatment?

18 May 2023 – From EuroPCR 2023

In this series of slides, uncover optimal treatments for multivessel disease: Evaluate revascularisation necessity, pinpoint when CABG excels, and identify prime scenarios for PCI.

 Multivessel disease - Which patients for PCI, CABG or medical treatment?

Solving complex mitral disease with transcatheter solutions

16 May 2023 – From EuroPCR 2023

This session compiles several complex scenarios such as severe mitral regurgitation induced by commissural prolapse, mitral regurgitation in non-obstructive hypertrophic cardiomyopathy, or mitral valve-in-valve in local anaesthesia, and explains how to overcome them!

Solving complex mitral disease with transcatheter solutions

Management of tricuspid valve regurgitation

11 Dec 2022

Watch the replay of the 2nd webinar on Tricuspid valve disease: patient pathways. You’ll learn all about 'Management of tricuspid valve regurgitation'

Mitral annular calcification - From diagnosis to treatment

29 Nov 2022 – From PCR London Valves 2022

Focus on mitral annular calcification: from diagnosis to treatment, learn more about the prevalence and clinical importance of MAC, understand the challenges of different therapeutic approaches and discover the current results and perspectives on transcatheter mitral valve implantation in patients with MAC.

Mitral annular calcification - From diagnosis to treatment

Patient-prosthesis mismatch: surgical and transcatheter approaches - LIVE case

28 Nov 2022 – From PCR London Valves 2022

Consult this session to discover different surgical and transcatheter approaches:

  • Part 1: Bioprosthesis aortic valve stenosis
    A 73-year-old male, with diabetes, BMI 29, atrial fibrillation, history of SAVR 15 years ago (Perimount 27) presents a symptomatic severe surgical valve stenosis with a preserved LV function.
    During the live time...
Patient-prosthesis mismatch: surgical and transcatheter approaches

Haemodynamic performance of transcatheter aortic valves: practical considerations for lifetime management

28 Nov 2022 – From PCR London Valves 2022

Watch this highly interactive session which focuses on the impact of haemodynamic performance on valve durability and patient survival, and how the design of bioprosthetic aortic valves influences clinical outcomes.

Primary mitral regurgitation: treatment options when the anatomy is complex

27 Nov 2022 – From PCR London Valves 2022

Take a look at these presentations to learn more about complex primary mitral regurgitation (and how to differentiate it from simple disease), to understand why it is complex and to know what the treatment options are.

Primary mitral regurgitation: treatment options when the anatomy is complex

Primary mitral regurgitation: key imaging requirements for diagnosis and procedural planning

27 Nov 2022 – From PCR London Valves 2022

In this session, find out more about the most common types of primary mitral regurgitation and methods for their evaluation, the principal indications for intervention, as well as the available modes of therapy (surgical/transcatheter) and most appropriate choices for individual patients.

Primary mitral regurgitation: key imaging requirements for diagnosis and procedural planning

Twenty years of progress - What we have achieved - LIVE case

27 Nov 2022 – From PCR London Valves 2022

  • Part 1: TAVI by axillary access (Live)
    An 80-year-old female with peripheral arterial disease presents a symptomatic severe aortic stenosis with small annulus and preserved LV function.
    The operators implant, by axillary access, an Evolut pro 26 mm, on general anaesthesia, with predilatation (Balloon 18 mm) and post-dilatation...
Twenty years of progress - What we have achieved

How to refine my TAVI procedure to ensure optimal long-term patient outcomes? - PCR roundtable discussion

In this video, join Lars Søndergaard, Lenard Conradi and Nicolas Van Mieghem as they discuss the importance of hemodynamic and valve durability in lifetime management of patients with aortic stenosis. You will also learn more about how to ensure coronary access after transcatheter aortic valve implantation...

How to refine my TAVI procedure to ensure optimal long-term patient outcomes?

How to ensure coronary access after transcatheter aortic valve implantation?

15 Jun 2022

Watch the replay of this webinar on TAVI with L. Conradi, H. Dreger and F. Ribichini on TAVI.

Tricuspid valve lifetime management

09 Aug 2022

Watch the replay of this PCR Webinar on tricuspid valve management with L. Sondergaard, H. Treede, N. Wunderlich, L. Conradi, J. Hausleiter and A. Latib

Transcatheter mitral valve implantation in challenging anatomies

20 May 2022 – From EuroPCR 2022

Discover a rare complication after transcatheter mitral valve-in-valve replacement, learn more about early TMVR in mitral annular calcification valve failure, witness a mitral bioprosthesis dysfunction after three previous stenotomies, and even more!

Transcatheter mitral valve implantation in challenging anatomies